Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Impact of low level of high-density lipoprotein-cholesterol sampled in overnight fasting state on the clinical outcomes in patients with acute myocardial infarction (difference between ST-segment and non-ST-segment-elevation myocardial infarction)

Authors
Ji, Mi SeonJeong, Myung HoAhn, Young KeunKim, Young JoChae, Shung ChullHong, Taek JongSeong, In WhanChae, Jei KeonKim, Chong JinCho, Myeong ChanRha, Seung-WoonBae, Jang HoSeung, Ki BaePark, Seung Jung
Issue Date
Jan-2015
Publisher
ELSEVIER
Keywords
Lipoproteins; Myocardial infarction; Mortality
Citation
JOURNAL OF CARDIOLOGY, v.65, no.1-2, pp.63 - 70
Indexed
SCIE
SCOPUS
Journal Title
JOURNAL OF CARDIOLOGY
Volume
65
Number
1-2
Start Page
63
End Page
70
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/94738
DOI
10.1016/j.jjcc.2014.04.002
ISSN
0914-5087
Abstract
Background: Despite good treatment, there are residual risks in acute myocardial infarction (AMI) patients, and low level of high-density lipoprotein-cholesterol (HDL) has drawn attention as a possible cause. However, the impact of low HDL on ST-segment-elevation myocardial infarction (STEMI) compared with non-ST-segment-elevation myocardial infarction (NSTEMI) is not clear. Our aim was to evaluate the impact of low HDL on clinical outcomes in patients with STEMI or NSTEMI. Methods: We included 9270 AMI patients undergoing successful percutaneous coronary intervention. They were grouped into STEMI and NSTEMI, and subdivided into two groups according to HDL level sampled in overnight fasting state. Primary end point was in-hospital death. Secondary end point was a composite of major adverse cardiac events (MACE) in hospital survivors during one-year follow-up. Results: In the STEMI population, low HDL group showed significantly higher in-hospital death rate [4.6% vs. 1.4%, hazard ratio (HR): 2.380, 95% confidence interval (CI): 1.143-4.956, p = 0.020] than normal HDL group. In NSTEMI population, there was no significant difference between two groups (1.8% vs. 0.9%, HR: 1.231, 95% CI: 0.649-2.335, p = 0.525), but in subgroup analysis, very low HDL subgroup showed higher in-hospital mortality rate compared with normal HDL group (4.0% vs. 0.9%, respectively, p = 0.009). In 12-month MACE rates, there was no significant difference between two groups in both populations. Conclusions: Low HDL was associated with significantly higher risk of in-hospital mortality in STEMI patients, but not in NSTEMI patients. Thus, more aggressive treatment should be considered in STEMI patients with low HDL. (C) 2014 Published by Elsevier Ltd on behalf of Japanese College of Cardiology.
Files in This Item
There are no files associated with this item.
Appears in
Collections
Graduate School > Department of Biomedical Sciences > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Rha, Seung Woon photo

Rha, Seung Woon
Department of Biomedical Sciences
Read more

Altmetrics

Total Views & Downloads

BROWSE